Compare off‑label appetite‑suppressing topiramate and GLP‑1 Ozempic — effectiveness, weight‑loss outcomes, safety insights, side‑effect patterns, pricing differences, and which option delivers stronger value for long‑term results.
See Full ComparisonOzempic (semaglutide) is a GLP-1 receptor agonist that significantly reduces appetite and improves satiety, leading to substantial weight loss. Topiramate is an off-label anticonvulsant that may reduce appetite and cravings, but with more variability in results.
| Feature | Ozempic ⭐ GLP-1 | Topiramate ⭐ Off-label |
|---|---|---|
| Rating |
★★★★★
|
★★★☆☆
|
| Weight Loss | 10–15% | 5–10% |
| Mechanism | GLP-1 appetite suppression | Neurological appetite reduction |
| Usage | Weekly injection | Daily oral tablet |
| Cost | High ($800+) | Low |
| Best for | Maximum weight loss | Budget appetite control |
| Check Options | Check Options | Check Options |
| Details | View Ozempic | View Topiramate |
Ozempic is significantly more effective for sustained weight loss due to its GLP-1 mechanism. Topiramate may be useful for patients seeking a low-cost, off-label alternative, but results are less predictable.
Check Ozempic OptionsCons: High cost, injection required
Cons: Off-label use, side effects, variable results
Is Ozempic more effective than Topiramate?
Yes, Ozempic generally produces significantly greater and more consistent weight loss results.
Can Topiramate be used for weight loss?
Yes, but it is used off-label and should be prescribed under medical supervision.
Which is cheaper?
Topiramate is significantly cheaper than Ozempic.
Which has fewer side effects?
Topiramate may have neurological side effects, while Ozempic may cause gastrointestinal symptoms.